Faik Ilik
Research Interests
Faik Ilik has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Ahmet Cemal Pazarlı
Department of Pulmonary Diseases, Tokat Gaziosmanpasa University Faculty of Medicine, Tokat, Turkey
2 shared publications - Devrimsel Harika Ertem
Silivri Anadolu Hospital, Department of Pain Management, Istanbul, Türkiye
2 shared publications - Fatih Kayhan
Department of Psychiatry, Selcuk University, Faculty of Medicine, Konya, Turkey
2 shared publications Hatice Kose Ozlece
Department of Neurology, Medical Faculty, Trakya University, Edirne, Turkey;†Department of Neurology, Medical Faculty, Kafkas University, Kars, Turkey;‡Department of Radiology, Adnan Menderes University, Medical Faculty, Aydın, Turkey; and§Department of Neurology, Konya Hospital, Baskent University, Konya, Turkey
2 shared publicationsNergiz Huseyinoglu
Department of Neurology, Medical Faculty, Kafkas University, Kars, Turkey
2 shared publicationsAyşegül Öğmegül
Necmettin Erbakan Üniversitesi, Meram Tıp Fakültesi, Konya Türkiye
1 shared publication
Latest Publications
- Open Access
- 22 May 2025
- Published by MDPI AG in Brain Sciences
- Vol. 15 (6) , 545
Still Relevant, Still Effective: A Retrospective Observational Cohort Study on Real-Life Use of Flunarizine in Episodic Migraine
Aim: New disease-specific and mechanism-based treatments for migraine that share good evidence of efficacy have recently been introduced. However, due to reimbursement problems with insurance companies and high costs, classical anti-migraine drugs continue to be used. The objective of this study was to assess the clinical efficacy and tolerability of flunarizine for the preventive treatment of episodic migraine without aura in a Turkish cohort, concentrating on alterations in headache frequency, pain intensity, and migraine-related disability as measured by MIDAS scores within a practical clinical environment. Methods: Clinical and demographic data of 243 patients with episodic migraine without aura (175 females, 68 males; mean age 33.9 years) were evaluated. Headache frequency, side effects of flunarizine, pain intensity, and MIDAS scores were recorded during initial and 3-month follow-up periods. Results: After three months of flunarizine treatment, significant improvements were observed in headache parameters. The mean Numeric Pain Rating Scale (NPRS) score, the mean MIDAS score, and the monthly migraine attack frequency declined significantly (all p values < 0.001). Adverse events were reported in 21.8% of patients, most commonly weight gain and tiredness, followed by mood changes, gastrointestinal symptoms, and numbness or tingling. Patients experiencing side effects were significantly older (p = 0.023), though side effects did not impact treatment efficacy. Regression analysis identified no significant predictors of disability improvement. Conclusion: Our results demonstrated that flunarizine had considerable short-term efficacy in decreasing the frequency of migraine attacks, alleviating headache severity, and reducing migraine-related disability among patients experiencing episodic migraine without aura. Although mild to moderate side effects were fairly prevalent, especially in older individuals, they did not compromise the effectiveness of the treatment. Notably, early adverse events occurring within the first two weeks resulted in treatment discontinuation for some patients, highlighting the necessity for vigilant monitoring during the initial phase of treatment.
- 22 May 2025
- Published by MDPI AG in Brain Sciences
- Vol. 15 (6) , 545
Open AccessStill Relevant, Still Effective: A Retrospective Observational Cohort Study on Real-Life Use of Flunarizine in Episodic Migraine
Aim: New disease-specific and mechanism-based treatments for migraine that share good evidence of efficacy have recently been introduced. However, due to reimbursement problems with insurance companies and high costs, classical anti-migraine drugs continue to be used. The objective of this study was to assess the clinical efficacy and tolerability of flunarizine for the preventive treatment of episodic migraine without aura in a Turkish cohort, concentrating on alterations in headache frequency, pain intensity, and migraine-related disability as measured by MIDAS scores within a practical clinical environment. Methods: Clinical and demographic data of 243 patients with episodic migraine without aura (175 females, 68 males; mean age 33.9 years) were evaluated. Headache frequency, side effects of flunarizine, pain intensity, and MIDAS scores were recorded during initial and 3-month follow-up periods. Results: After three months of flunarizine treatment, significant improvements were observed in headache parameters. The mean Numeric Pain Rating Scale (NPRS) score, the mean MIDAS score, and the monthly migraine attack frequency declined significantly (all p values < 0.001). Adverse events were reported in 21.8% of patients, most commonly weight gain and tiredness, followed by mood changes, gastrointestinal symptoms, and numbness or tingling. Patients experiencing side effects were significantly older (p = 0.023), though side effects did not impact treatment efficacy. Regression analysis identified no significant predictors of disability improvement. Conclusion: Our results demonstrated that flunarizine had considerable short-term efficacy in decreasing the frequency of migraine attacks, alleviating headache severity, and reducing migraine-related disability among patients experiencing episodic migraine without aura. Although mild to moderate side effects were fairly prevalent, especially in older individuals, they did not compromise the effectiveness of the treatment. Notably, early adverse events occurring within the first two weeks resulted in treatment discontinuation for some patients, highlighting the necessity for vigilant monitoring during the initial phase of treatment.
- 1 October 2019
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 33, 154-157
Evaluation of burden and depression among caregivers of stroke patients: The role of percutaneous endoscopic gastrostomy feeding tube
- 1 October 2019
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 33, 154-157
Evaluation of burden and depression among caregivers of stroke patients: The role of percutaneous endoscopic gastrostomy feeding tube
- Open Access
- 31 October 2017
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 11 (10) , 753-758
Frequency of subclinical peripheral neuropathy in cases of untreated brucellosis
Introduction: Brucellosis is a common zoonotic disease in some areas of the world. It may affect several organs and is known to involve the nervous system in 2.7–17.8% of affected patients. During the progression of brucellosis, peripheral neuropathies (PNs) have been reported. However, there are few studies investigating the presence of subclinical neuropathy in asymptomatic patients. In our study, we aimed to evaluate the presence of peripheral neuropathy using electrophysiological methods in newly-diagnosed untreated brucellosis patients. Methodology: The study included a control group of 60 healthy volunteers and 60 untreated brucellosis patients with a positive result of 1/160 or above on a brucella tube agglutination test. The patient and control groups were evaluated by electrophysiological methods. Results: In the patient group, all investigated motor nerves had slower average motor conduction speeds, reduced compound muscle action potential (CMAP) amplitudes and delayed F response and terminal latency compared to the control group. The sural nerve sensory conduction speed was slower and the sensory nerve action potential (SNAP) was found to be reduced. Conclusion: Among the 60 patients with acute brucellosis, 18% had sensorimotor peripheral neuropathy of widespread axonal character. Brucellosis can have many effects in the nervous system, including clinical or subclinical peripheral neuropathy in the peripheral nervous system. Brucellosis should be considered for differential diagnosis of patients with unexplained neurological and clinically relevant electrophysiological findings, especially in regions with endemic brucellosis.
- 31 October 2017
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 11 (10) , 753-758
Open AccessFrequency of subclinical peripheral neuropathy in cases of untreated brucellosis
Introduction: Brucellosis is a common zoonotic disease in some areas of the world. It may affect several organs and is known to involve the nervous system in 2.7–17.8% of affected patients. During the progression of brucellosis, peripheral neuropathies (PNs) have been reported. However, there are few studies investigating the presence of subclinical neuropathy in asymptomatic patients. In our study, we aimed to evaluate the presence of peripheral neuropathy using electrophysiological methods in newly-diagnosed untreated brucellosis patients. Methodology: The study included a control group of 60 healthy volunteers and 60 untreated brucellosis patients with a positive result of 1/160 or above on a brucella tube agglutination test. The patient and control groups were evaluated by electrophysiological methods. Results: In the patient group, all investigated motor nerves had slower average motor conduction speeds, reduced compound muscle action potential (CMAP) amplitudes and delayed F response and terminal latency compared to the control group. The sural nerve sensory conduction speed was slower and the sensory nerve action potential (SNAP) was found to be reduced. Conclusion: Among the 60 patients with acute brucellosis, 18% had sensorimotor peripheral neuropathy of widespread axonal character. Brucellosis can have many effects in the nervous system, including clinical or subclinical peripheral neuropathy in the peripheral nervous system. Brucellosis should be considered for differential diagnosis of patients with unexplained neurological and clinically relevant electrophysiological findings, especially in regions with endemic brucellosis.
- 1 October 2016
- Published by Wolters Kluwer Health in Journal Of Clinical Neurophysiology
- Vol. 33 (5) , 464-468
Ultrasonographic and Electrophysiological Evaluation of the Ulnar Nerve in Patients Diagnosed With Carpal Tunnel Syndrome
In this study, we evaluated the ulnar nerve of patients diagnosed with carpal tunnel syndrome (CTS) using electrophysiology and ultrasonography. The study included 86 patients (136 hands) and 39 controls (78 hands) with normal electrophysiological assessment. According to Bland's classification, patients were divided into group 1 (grades 1–3 CTS) or group 2 (grades 4–6 CTS). The ulnar nerve was evaluated at the wrist using nerve conduction studies and ultrasonography. The sensory velocity was slower in group 2 than in group 1 (P < 0.001), slower in group 2 than in controls (P < 0.001), and slower in group 1 than in controls (P < 0.005). Although the ultrasonography results showed a reduction in the ulnar nerve cross-sectional area in group 1 compared with controls, the difference was not statistically significant. However, the reduction was significant in group 2 compared with group 1 and controls (P < 0.001). Based on our study results, the ulnar nerve is affected electrophysiologically and morphologically in patients with CTS, especially those with advanced-stage CTS.
- 1 October 2016
- Published by Wolters Kluwer Health in Journal Of Clinical Neurophysiology
- Vol. 33 (5) , 464-468
Ultrasonographic and Electrophysiological Evaluation of the Ulnar Nerve in Patients Diagnosed With Carpal Tunnel Syndrome
In this study, we evaluated the ulnar nerve of patients diagnosed with carpal tunnel syndrome (CTS) using electrophysiology and ultrasonography. The study included 86 patients (136 hands) and 39 controls (78 hands) with normal electrophysiological assessment. According to Bland's classification, patients were divided into group 1 (grades 1–3 CTS) or group 2 (grades 4–6 CTS). The ulnar nerve was evaluated at the wrist using nerve conduction studies and ultrasonography. The sensory velocity was slower in group 2 than in group 1 (P < 0.001), slower in group 2 than in controls (P < 0.001), and slower in group 1 than in controls (P < 0.005). Although the ultrasonography results showed a reduction in the ulnar nerve cross-sectional area in group 1 compared with controls, the difference was not statistically significant. However, the reduction was significant in group 2 compared with group 1 and controls (P < 0.001). Based on our study results, the ulnar nerve is affected electrophysiologically and morphologically in patients with CTS, especially those with advanced-stage CTS.
- 30 September 2016
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 41 (18992) , 564-561
Asemptomatik erişkin hastada insidental korpus kallosum agenezesi ve kolposefali
- 30 September 2016
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 41 (18992) , 564-561
Asemptomatik erişkin hastada insidental korpus kallosum agenezesi ve kolposefali
- 1 July 2016
- Published by Elsevier in Comprehensive Psychiatry
- Vol. 68, 60-64
Prevalence of personality disorders in patients with chronic migraine
- 1 July 2016
- Published by Elsevier in Comprehensive Psychiatry
- Vol. 68, 60-64
Prevalence of personality disorders in patients with chronic migraine
- Open Access
- 1 January 2016
- Published by Armed Forces Medical Services in Neurosciences
- Vol. 21 (1) , 26-29
Electrophysiological assessment in patients with long term hypoxia
To evaluate visual evoked potentials (VEP) patterns in chronic obstructive pulmonary disease (COPD) patients who were compliant with supplemental oxygen treatment relative to non-compliant COPD patients. This prospective study protocol was reviewed and approved by the local ethical committee of Selcuk University and the research was performed in the Department of Neurology, Elbistan State Hospital, Kahramanmaras, Turkey from May to October 2014. Blood gas measurements and pulmonary function tests were carried out in patients with advanced stage COPD. The VEP was assessed in both eyes in both compliant and non-compliant patients. The study included 43 patients; 24 (55.8%) of the patients were not in compliance with their supplemental oxygen treatment, while 19 patients (44.2%) received adequate oxygen treatment. There was no statistically significant difference between patients with regards to pulmonary function test results and blood gas measurements. The VEP latency was significantly greater in both eyes of the non-compliant patients. Previous studies have reported prolonged VEP latencies in inflammatory diseases of the central nervous system. Similar electrophysiological findings were observed in our study and we propose that this may be due to oxidative stress, and inflammation that occurs secondary to chronic ischemia.
- 1 January 2016
- Published by Armed Forces Medical Services in Neurosciences
- Vol. 21 (1) , 26-29
Open AccessElectrophysiological assessment in patients with long term hypoxia
To evaluate visual evoked potentials (VEP) patterns in chronic obstructive pulmonary disease (COPD) patients who were compliant with supplemental oxygen treatment relative to non-compliant COPD patients. This prospective study protocol was reviewed and approved by the local ethical committee of Selcuk University and the research was performed in the Department of Neurology, Elbistan State Hospital, Kahramanmaras, Turkey from May to October 2014. Blood gas measurements and pulmonary function tests were carried out in patients with advanced stage COPD. The VEP was assessed in both eyes in both compliant and non-compliant patients. The study included 43 patients; 24 (55.8%) of the patients were not in compliance with their supplemental oxygen treatment, while 19 patients (44.2%) received adequate oxygen treatment. There was no statistically significant difference between patients with regards to pulmonary function test results and blood gas measurements. The VEP latency was significantly greater in both eyes of the non-compliant patients. Previous studies have reported prolonged VEP latencies in inflammatory diseases of the central nervous system. Similar electrophysiological findings were observed in our study and we propose that this may be due to oxidative stress, and inflammation that occurs secondary to chronic ischemia.
- Open Access
- 4 April 2015
- Vol. 14 (2) , 116-117
Coexistence of Ehlers-Danlos syndrome and multiple sclerosis
- 4 April 2015
- Vol. 14 (2) , 116-117
Open AccessCoexistence of Ehlers-Danlos syndrome and multiple sclerosis
- Open Access
- 5 March 2015
- Published by Cagdas Tip Dergisi: Journal of Contemporary Medicine in Journal of Contemporary Medicine
Wallenberg Sendromu'na Neden Olan Vertebral Arter Diseksiyonu
- 5 March 2015
- Published by Cagdas Tip Dergisi: Journal of Contemporary Medicine in Journal of Contemporary Medicine
Open AccessWallenberg Sendromu'na Neden Olan Vertebral Arter Diseksiyonu
- 9 July 2014
- Published by SAGE Publications in Clinical Eeg and Neuroscience
- Vol. 46 (3) , 263-265
Reflex Epilepsy Triggered by Smell
Reflex epilepsies can be provoked by various types of external stimuli, but triggered by smell is rare in the literature. In this case report, we present a patient whose reflex epilepsy is triggered by smell. Physical examination findings and electrophysiologic studies of the patient are discussed.
- 9 July 2014
- Published by SAGE Publications in Clinical Eeg and Neuroscience
- Vol. 46 (3) , 263-265
Reflex Epilepsy Triggered by Smell
Reflex epilepsies can be provoked by various types of external stimuli, but triggered by smell is rare in the literature. In this case report, we present a patient whose reflex epilepsy is triggered by smell. Physical examination findings and electrophysiologic studies of the patient are discussed.